Illumina, Inc. (ILMN)
NASDAQ: ILMN · IEX Real-Time Price · USD
122.87
-1.59 (-1.28%)
At close: Apr 24, 2024, 4:00 PM
123.25
+0.38 (0.31%)
After-hours: Apr 24, 2024, 6:36 PM EDT
Illumina Market Cap
Illumina has a market cap or net worth of $19.52 billion as of April 24, 2024. Its market cap has decreased by -46.27% in one year.
Market Cap
19.52B
Enterprise Value
20.57B
1-Year Change
-46.27%
Ranking
Category
Stock Price
$122.87
Market Cap Chart
Since July 28, 2000, Illumina's market cap has increased from $1.24B to $19.52B, an increase of 1,480.25%. That is a compound annual growth rate of 12.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 19.78B | 3.50% |
Apr 22, 2024 | 19.11B | 2.40% |
Apr 19, 2024 | 18.66B | 0.63% |
Apr 18, 2024 | 18.54B | -1.35% |
Apr 17, 2024 | 18.80B | 0.51% |
Apr 16, 2024 | 18.70B | -2.86% |
Apr 15, 2024 | 19.25B | -4.65% |
Apr 12, 2024 | 20.19B | -2.78% |
Apr 11, 2024 | 20.77B | -0.36% |
Apr 10, 2024 | 20.84B | -1.80% |
Apr 9, 2024 | 21.22B | 2.65% |
Apr 8, 2024 | 20.68B | 1.86% |
Apr 5, 2024 | 20.30B | 1.39% |
Apr 4, 2024 | 20.02B | -1.36% |
Apr 3, 2024 | 20.30B | -0.61% |
Apr 2, 2024 | 20.42B | -3.16% |
Apr 1, 2024 | 21.09B | -3.35% |
Mar 28, 2024 | 21.82B | -0.98% |
Mar 27, 2024 | 22.04B | 3.65% |
Mar 26, 2024 | 21.26B | -0.19% |
Mar 25, 2024 | 21.30B | -2.32% |
Mar 22, 2024 | 21.81B | -0.15% |
Mar 21, 2024 | 21.84B | 3.20% |
Mar 20, 2024 | 21.16B | 0.02% |
Mar 19, 2024 | 21.16B | 2.32% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
argenx SE | 22.55B |
Molina Healthcare | 21.38B |
BioNTech SE | 21.08B |
Baxter International | 20.64B |
STERIS | 20.35B |
Koninklijke Philips | 19.02B |
Genmab | 18.74B |
Alnylam Pharmaceuticals | 18.65B |